Do you offer adjuvant chemoimmunotherapy after IFRT for Stage I to II low grade follicular lymphoma?  

TROG 99.03 showed nearly 20% improved PFS at 10 years with chemoimmunotherapy despite 31/75 patients assigned R-CVP vs 44/75 assigned CVP without rituximab.  If you do offer treatment, what factors into your decision?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution